Related Experiment Video
Updated: Dec 22, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification
Duk-Hwa Kwon1, Juhee Ryu1, Young-Kook Kim2
1Department of Pharmacology, Chonnam National University Medical School, Hwasun 58128, Korea.
Insights
Vascular calcification (VC) involves calcium buildup in arteries, linked to cardiovascular diseases. Epigenetic regulators, like histone deacetylases, offer potential therapeutic targets for treating VC.
Area of Science:
- Biomedical Science
- Cardiovascular Research
- Epigenetics
Background:
- Vascular calcification (VC) is arterial calcium deposition, a major risk factor for cardiovascular diseases (CVDs), atherosclerosis, diabetes, and chronic kidney disease.
- VC is an active cellular process involving vascular smooth muscle cells (VSMCs) transitioning to an osteochondrogenic phenotype, mimicking bone formation.
- Epigenetic factors such as DNA methylation, histone modification, and noncoding RNAs significantly regulate VC development.
Purpose of the Study:
- To review current evidence on the role of epigenetic regulators in VC.
- To explore histone deacetylases (HDACs) as key epigenetic factors in VC.
- To propose therapeutic implications of targeting epigenetic regulators for VC treatment.
Main Methods:
- Literature review of experimental evidence on VC and epigenetic regulation.
- Focus on studies investigating histone deacetylases (HDACs) in the context of VC.
- Analysis of the link between epigenetic mechanisms and VSMC phenotype switching.
Main Results:
- VC is an active process in VSMCs, sharing similarities with bone formation.
- Epigenetic modifications, including histone modifications by HDACs, play a crucial role in regulating VC.
- Evidence suggests HDACs are implicated in the osteochondrogenic differentiation of VSMCs during VC.
Conclusions:
- Epigenetic regulators, particularly histone deacetylases, are critical in the pathogenesis of vascular calcification.
- Targeting epigenetic mechanisms, specifically HDACs, presents a promising therapeutic strategy for VC.
- Further research into HDAC inhibitors could lead to novel treatments for VC and associated cardiovascular conditions.
Abstract:
Vascular calcification (VC) is characterized by calcium deposition inside arteries and is closely associated with the morbidity and mortality of atherosclerosis, chronic kidney disease, diabetes, and other cardiovascular diseases (CVDs). VC is now widely known to be an active process occurring in vascular smooth muscle cells (VSMCs) involving multiple mechanisms and factors. These mechanisms share features with the process of bone formation, since the phenotype switching from the contractile to the osteochondrogenic phenotype also occurs in VSMCs during VC. In addition, VC can be regulated by epigenetic factors, including DNA methylation, histone modification, and noncoding RNAs. Although VC is commonly observed in patients with chronic kidney disease and CVD, specific drugs for VC have not been developed. Thus, discovering novel therapeutic targets may be necessary. In this review, we summarize the current experimental evidence regarding the role of epigenetic regulators including histone deacetylases and propose the therapeutic implication of these regulators in the treatment of VC.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Spreading of Chromatin Modifications
Writers
The writer...

